SCHEMBL6990585

SCHEMBL6990585

Cc1ccc(O)c(CC(=O)NO)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 1/20 0.49
ANO1 Q5XXA6 1/20 0.48
CSNK2A1 P68400 1/20 0.47
NPSR1 Q6W5P4 1/20 0.44
HTT P42858 1/20 0.44
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43
HDAC5 Q9UQL6 2/20 0.43
GAA P10253 1/20 0.43
RAB9A P51151 2/20 0.42
TRPA1 O75762 1/20 0.42
MEP1B Q16820 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27471976 1.00 AMY1A (0.49) AMY1AANO1CSNK2A1NPSR1HTT
SCHEMBL27745589 0.79 SRC (0.56) AMY1ACSNK2A1HTTGAATRPA1
SCHEMBL6992645 0.79 HIF1A (0.55) ANO1HTTPOLBMEN1LMNA
SCHEMBL12646581 0.79 EGFR (0.56) AMY1AANO1CSNK2A1NPSR1HTT
SCHEMBL5724601 0.78 AMY1A (0.52) AMY1AANO1CSNK2A1NPSR1HTT
SCHEMBL13068104 0.76 AMY1A (0.50) AMY1AANO1CSNK2A1NPSR1HTT
SCHEMBL24802456 0.75 AMY1A (0.49) AMY1AANO1CSNK2A1NPSR1HTT
SCHEMBL11055371 0.75 KMT2A (0.42) NPSR1HDAC1HDAC8HDAC6MEP1B
SCHEMBL1023280 0.74 AMY1A (0.61) AMY1ACSNK2A1NPSR1HTTGAA
SCHEMBL21456017 0.74 EGFR (0.58) AMY1ACSNK2A1HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed